Edwards Lifesciences Corp is 2.9x more valuable than ZIMMER BIOMET HOLDINGS, INC. by market capitalization ($49.51 B vs $16.89 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | EW | ZBH |
|---|---|---|
| Market cap | $49.51 B | $16.89 B |
| US-listed rank | #320 | #684 |
| Revenue (latest FY) | $6.07B | $8.23B |
| Net income (latest FY) | $1.07B | $705.10M |
| Net margin | 17.7% | 8.6% |
| P/E (trailing FY) | 46.1 | 24.0 |
| SEC filings | 2,569 | 1,000 |
Edwards Lifesciences Corp is 2.9x more valuable than ZIMMER BIOMET HOLDINGS, INC. by market capitalization ($49.51 B vs $16.89 B).
In their latest fiscal years, Edwards Lifesciences Corp reported $6.07B in revenue while ZIMMER BIOMET HOLDINGS, INC. reported $8.23B.
Full pages: Edwards Lifesciences Corp and ZIMMER BIOMET HOLDINGS, INC., or browse the full rankings.